Blog

ACHIEVING THE PROMISE OF NEW PrEP PRODUCTS TO PREVENT HIV

After more than a decade in which only one PrEP option — a daily pill — was available to prevent acquiring HIV, several new PrEP products are entering the scene. But a big test is ahead for these formulations: Will they be introduced in a way that is accessible, acceptable and affordable to those who need them most?

Continue Reading

Events

MOSAIC AT HIVR4P 2024

MOSAIC is heading to Lima, Peru, for the HIV Research for Prevention Conference (HIVR4P 2024). We invite conference attendees to join us for the following sessions.

Continue Reading

Events

MOSAIC AT AIDS 2024

MOSAIC is heading to Munich, Germany, for the International AIDS Conference (AIDS 2024). We invite conference attendees to join us for the following sessions.

Continue Reading

Blog

INTEREST 2024 KEY TAKEAWAYS

Last week, MOSAIC staff from Nigeria traveled to Cotonou, Benin, for the International Conference on HIV Treatment, Pathogenesis, and Prevention Research (INTEREST). They participated in the conference in person and, in this post, share their reflections.

Continue Reading

Blog

JUMP-STARTING PrEP INTRODUCTION: LEVERAGING MOSAIC’S TEMPLATE GUIDELINES TO CREATE AN ENABLING POLICY ENVIRONMENT

When a country is poised to introduce a new biomedical prevention product, policymakers want to ensure that their rollout plan is based on the latest science and provides clear, standardized procedures for implementation. The WHO publishes global guidance on delivering new HIV prevention products, but those recommendations need to be adapted to the local context. 

Continue Reading